Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Trials to Evaluate the Efficacy and Toxicity of Sirolimus/Tacrolimus Combination as a GVHD Prophylaxis After HLA Matched Related PBSCT

NCT01488253 is registered in ClinicalTrials.gov with The Korean Society of Blood and Marrow Transplantation as lead sponsor.

NCT NCT01488253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01488253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Trials to Evaluate the Efficacy and Toxicity of Sirolimus/Tacrolimus Combination as a GVHD Prophylaxis After HLA Matched Related PBSCT
Lead sponsor
The Korean Society of Blood and Marrow Transplantation
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2012
Completion date
October 31, 2014
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia in remission, leukemia, myeloid, accelerated-phase, leukemia, myeloid, chronic-phase, myelodysplastic syndromes